Announcements Trials
Browse Landscape

Phase

Phase EARLY_PHASE1 1Phase 2 1

Status

Completed 1

Sponsor Class

OTHER 1

Study Type

Interventional 1

Sponsor

Cancer Type

Plasma cell 1

Conditions

Primary Myelofibrosis 1Neoplasms, Plasma Cell 1Myelodysplastic-Myeloproliferative Diseases 1Myelodysplastic Syndromes 1Leukemia, Myelomonocytic, Chronic 1Leukemia, Myeloid, Chronic, Atypical, BCR-ABL Negative 1Leukemia, Myeloid, Acute 1Leukemia, Myeloid 1

Interventions

fludarabine 2Granulocyte Colony-Stimulating Factor 2Cyclophosphamide 2inebilizumab 1Sirolimus 1Positron-Emission Tomography 1Pemetrexed 1Lenalidomide 1Interleukin-6 1Hyperbaric Oxygenation 1Hydroxychloroquine 1Filgrastim 1Dexamethasone 1Bortezomib 1Blood Specimen Collection 113-valent pneumococcal vaccine 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
Phase EARLY_PHASE1 × Neoplasms, Plasma Cell × Hyperbaric Oxygenation × Clear all
NCT04862676 2025-09-10

Repeated HBO Therapy in Myeloma Patients Undergoing High-Dose Therapy and Auto-HCT

University of Rochester

Phase EARLY_PHASE1 Completed
29 enrolled
Plasma cell

Neoplasms, Plasma Cell

Data powered by HemOnc (CC BY 4.0) Colophon âš¡